Elevation Oncology Ownership | Who Owns Elevation Oncology?

Overview Forecast RevenueFinancials Chart

Elevation Oncology Ownership Summary

Elevation Oncology is owned by 77.72% institutional investors, 0.24% insiders, and 22.04% retail investors. Farallon capital management is the largest institutional shareholder, holding 6.10% of ELEV shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.77% of its assets in Elevation Oncology shares.

ELEV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Elevation Oncology	77.72%	0.24%	22.04%
Sector	Healthcare Stocks	46.62%	8.13%	45.25%
Industry	Biotech Stocks	44.91%	7.98%	47.11%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Farallon capital management	3.60M	6.10%	$9.72M
Tang capital management	3.06M	5.18%	$8.26M
Frazier life sciences management	2.96M	5.01%	$7.99M
Aisling capital management lp	2.83M	4.80%	$7.65M
Blackrock	2.49M	4.22%	$6.72M
Braidwell lp	2.48M	4.20%	$6.69M
Hudson bay capital management lp	2.40M	4.06%	$6.47M
Bvf inc/il	2.31M	3.92%	$6.24M
Vanguard group	1.92M	3.25%	$5.18M
Palo alto investors lp	1.80M	3.05%	$4.86M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aisling capital management lp	2.83M	3.31%	$7.65M
Tang capital management	3.06M	0.84%	$8.26M
Palo alto investors lp	1.80M	0.56%	$4.86M
Frazier life sciences management	2.96M	0.37%	$7.99M
Ikarian capital	690.09K	0.32%	$1.86M
Braidwell lp	2.48M	0.21%	$6.69M
Bvf inc/il	2.31M	0.17%	$6.24M
Sphera funds management	330.00K	0.12%	$891.00K
Artal group	1.01M	0.07%	$2.74M
Orbimed advisors	941.27K	0.05%	$2.54M

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	2.96M	0.37%	2.96M
Blackrock	2.49M	0.00%	2.32M
Morgan stanley	1.27M	0.00%	1.25M
Hudson bay capital management lp	2.40M	0.03%	886.87K
State street	897.03K	0.00%	786.43K

Top Sellers

Holder	Shares	% Assets	Change
Logos global management lp	-	-	-3.85M
Balyasny asset management	-	-	-2.48M
Venbio partners	-	-	-2.43M
Darwin global management	-	-	-1.92M
Point72 asset management	-	-	-1.68M

New Positions

Holder	Shares	% Assets	Change	Value
Frazier life sciences management	2.96M	0.37%	2.96M	$7.99M
Bank of new york mellon	153.59K	0.00%	153.59K	$414.68K
Charles schwab investment management	134.55K	0.00%	134.55K	$363.27K
Wellington management group llp	116.07K	0.00%	116.07K	$313.38K
Nuveen asset management	81.19K	0.00%	81.19K	$219.21K

Sold Out

Holder	Change
Macquarie group	-1.27K
Ctc alternative strategies	-11.10K
Sg americas securities	-12.24K
Marathon trading investment management	-13.71K
Metlife investment management	-14.46K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	69	-14.81%	45,936,801	-11.86%	77	1.00%	39	-25.00%	17	-19.05%
Jun 30, 2024	81	26.56%	52,117,516	18.46%	88	1.02%	52	1.96%	21	133.33%
Mar 31, 2024	64	106.45%	43,997,469	70.21%	92	2.50%	51	628.57%	9	28.57%
Dec 31, 2023	31	-22.50%	25,848,863	-7.84%	60	1.39%	7	-65.00%	7	16.67%
Sep 30, 2023	40	-	28,047,314	-11.07%	66	0.51%	20	-25.93%	6	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.64M	2.77%	-
iShares Russell 2000 ETF	1.32M	2.23%	-2.95K
Vanguard Institutional Extnd Mkt Idx Tr	608.57K	1.03%	-
Fidelity Small Cap Index	547.18K	0.93%	-1.85K
Vanguard US Momentum Factor ETF	430.42K	0.73%	430.42K
State St Russell Sm/Mid Cp® Indx NL Cl C	321.51K	0.54%	-
Fidelity Extended Market Index	301.03K	0.51%	44.50K
iShares Russell 2000 Growth ETF	280.18K	0.47%	-
Aesculape SRI IC	260.00K	0.44%	260.00K
State St Russell Sm Cap® Indx SL Cl I	241.40K	0.41%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 25, 2022	venBio Global Strategic Fund III, L.P.	-	Sell	$2.90M
May 25, 2022	Royston Aaron		Sell	$2.90M
Jun 29, 2021	Qiming U.S. Healthcare Fund II, L.P.	-	Buy	$5.00M
Jun 29, 2021	Aisling Capital IV, LP	-	Buy	$3.00M
Jun 29, 2021	venBio Global Strategic Fund III, L.P.	-	Buy	$10.00M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	-	-

ELEV Ownership FAQ

Who Owns Elevation Oncology?

Elevation Oncology shareholders are primarily institutional investors at 77.72%, followed by 0.24% insiders and 22.04% retail investors. The average institutional ownership in Elevation Oncology's industry, Biotech Stocks , is 44.91%, which Elevation Oncology exceeds.

Who owns the most shares of Elevation Oncology?

Elevation Oncology’s largest shareholders are Farallon capital management (3.6M shares, 6.10%), Tang capital management (3.06M shares, 5.18%), and Frazier life sciences management (2.96M shares, 5.01%). Together, they hold 16.29% of Elevation Oncology’s total shares outstanding.

Does Blackrock own Elevation Oncology?

Yes, BlackRock owns 4.22% of Elevation Oncology, totaling 2.49M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.72M$. In the last quarter, BlackRock increased its holdings by 2.32M shares, a 1348.65% change.

Who is Elevation Oncology’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is Elevation Oncology’s biggest shareholder by percentage of total assets invested, with 3.31% of its assets in 2.83M Elevation Oncology shares, valued at 7.65M$.

Who is the top mutual fund holder of Elevation Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Elevation Oncology shares, with 2.77% of its total shares outstanding invested in 1.64M Elevation Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools